Elizabeth H. Federici

Hematology
500 University Dr
Hershey, PA 17033

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications

Prescribing preferences for reduced-dose direct oral anticoagulation for extended-phase venous thromboembolism treatment.

Prescribing preferences for reduced-dose direct oral anticoagulation for extended-phase venous thromboembolism treatment.

Journal: Thrombosis research
Published: March 18, 2025

Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment.

Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment.

Journal: Journal of clinical medicine
Published: December 02, 2023

Feasibility of a tailored home-based exercise intervention during neoadjuvant chemotherapy in breast cancer patients.

Feasibility of a tailored home-based exercise intervention during neoadjuvant chemotherapy in breast cancer patients.

Journal: BMC sports science, medicine & rehabilitation
Published: June 29, 2021

Post-transfusion hemoglobin response in patients with cirrhosis: Can we expect a 1 g/dL rise per unit transfused?

Post-transfusion hemoglobin response in patients with cirrhosis: Can we expect a 1 g/dL rise per unit transfused?

Journal: Transfusion
Published: August 04, 2020

High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A.

High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A.

Journal: Thrombosis research
Published: January 14, 2019
Showing 1-5 of 5

Last Updated: 09/26/2026